143 related articles for article (PubMed ID: 14712886)
1. The adjunctive effect of telmisartan in patients with hypertension uncontrolled on current antihypertensive therapy.
Gil-Extremera B; Ma PT; Yulde J; Kalnins U; Harkin N; Williams L
Int J Clin Pract; 2003 Dec; 57(10):861-6. PubMed ID: 14712886
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
Lacourcière Y; Neutel JM; Davidai G; Koval S
Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
5. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
[TBL] [Abstract][Full Text] [Related]
8. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
Smith DH; Matzek KM; Kempthorne-Rawson J
J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
[TBL] [Abstract][Full Text] [Related]
10. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
Neldam S; Edwards C; Jones R;
Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
[TBL] [Abstract][Full Text] [Related]
11. Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies.
Smith DH; Cramer MJ; Neutel JM; Hettiarachchi R; Koval S
Blood Press Monit; 2003 Jun; 8(3):111-7. PubMed ID: 12900588
[TBL] [Abstract][Full Text] [Related]
12. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
White WB; Lacourciere Y; Davidai G
Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
[TBL] [Abstract][Full Text] [Related]
13. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study.
Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM;
J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy.
Lacourcière Y; Tytus R; O'Keefe D; Lenis J; Orchard R; Martin K
J Hum Hypertens; 2001 Nov; 15(11):763-70. PubMed ID: 11687919
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial.
Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM
Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
[TBL] [Abstract][Full Text] [Related]
17. Sustained decrease in blood pressure following missed doses of aliskiren or telmisartan: the ASSERTIVE double-blind, randomized study.
Düsing R; Brunel P; Baek I; Baschiera F
J Hypertens; 2012 May; 30(5):1029-40. PubMed ID: 22441345
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients.
Guthrie RM; Dahlöf B; Jamerson KA; Olvera R; Seeber M; Schumacher H; Oigman W
Curr Med Res Opin; 2011 Oct; 27(10):1995-2008. PubMed ID: 21905967
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension.
Neutel JM; Littlejohn TW; Chrysant SG; Singh A;
Hypertens Res; 2005 Jul; 28(7):555-63. PubMed ID: 16335883
[TBL] [Abstract][Full Text] [Related]
20. ABPM comparison of the anti-hypertensive profiles of telmisartan and enalapril in patients with mild-to-moderate essential hypertension.
Amerena J; Pappas S; Ouellet JP; Williams L; O'Shaughnessy D
J Int Med Res; 2002; 30(6):543-52. PubMed ID: 12526280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]